A possible clinical application of HT-47 and WRK-30 could therefore be the prevention of bacterial adhesion to prosthetic materials by coating the AMPs to the biomaterial [11,12], thereby preventing the risk of septic arthritis in joint replacement surgeries and in all other surgeries requiring implanting biomaterials [13]. The gene discussed is ADSL; the disease is bacterial arthritis.